2008•Critical CareOpen access

Hemodynamic effects of levosimendan in patients with low-output heart failure

Hédi Gharsallah, Miguel Amor, W. Koubaa, Faten Gargouri, Khaled Lamine, Mustapha Ferjani

Abstract

Levosimendan is a positive inotropic drug agent that increases the sensibility of contractile proteins to calcium [ 1 ]. The drug is used in patients with decompensated low-output heart failure [ 2 ]. The aim of our study is to analyze the hemodynamic effects of levosimendan in patients with refractory cardiogenic shock.

Open-access reader

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Levosimendan, Medicine, Inotrope, Cardiogenic shock, Hemodynamics, Cardiology, Heart failure, Internal medicine